Cartesian Therapeutics Competitors and Similar CompaniesClear all
Cartesian Therapeutics's competitors and similar companies include Ipsen and Vertex Pharmaceuticals.
 Cartesian Therapeutics Cartesian Therapeutics (formerly Selecta Biosciences) is a clinical-stage biopharmaceutical company advancing a differentiated product pipeline to modulate the immune system. |  Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines. | ||
Founding Date | Founding Date 2007 | Founding Date 1929 | Founding Date 1989 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Watertown, US HQ | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | |
Employees | Employees 15 | Employees 5,358 | Employees 5,40013% increase |
Valuation ($) | Valuation ($) 536.3 m | Valuation ($) 10.2 b | Valuation ($) 121.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) $2.8m (FY, 2025) | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) $12b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €659.1m (FY, 2025) | Cost of goods $1.7b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €3.3b (FY, 2025) | Gross profit $10.4b (FY, 2025) |
Net income | Net income ($130.3m) (FY, 2025) | Net income €445.1m (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 167.7m | Total funding raised N/A | Total funding raised $ 2.4m |
For sources of this data, please see the company profile
View Company Profiles
Vertex Pharmaceuticals
HQ
Boston, US
Employees
5,400↑ 13% increase
Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.
View company